Approval Year
| Classification Tree | Code System | Code |
|---|
Classification Tree | Code System | Code | ||||
|---|---|---|---|---|---|---|
|
NDF-RT | N0000007672 | ||||
|
WHO-ATC | A07AA02 | ||||
|
WHO-VATC | QG01AA01 | ||||
|
NCI_THESAURUS | C514 | ||||
|
WHO-ESSENTIAL MEDICINES LIST | 6.3 |
Showing 1 to 5 of 19 entries
| Code System | Code | Type | Description |
|---|
Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
BDF1O1C72E | PRIMARY | |||
|
7597 | PRIMARY | RxNorm | ||
|
NYSTATIN | PRIMARY | Description: A yellow to light brown powder.Solubility: Very slightly soluble in water; sparingly soluble in ethanol (~750 g/l) TS and methanol R; practically insoluble in ether R. Category: Antifungal drug. Storage: Nystatin should be kept in a tightly closed container, protected from light and stored at a temperature not exceeding 5?C. Additional information: Nystatin is hygroscopic. Even in the absence of light, it is gradually degraded on exposure to a humidatmosphere, the decomposition being faster at higher temperatures. The potency of Nystatin may fall at a rate of 1% per monthwhen it is stored under the conditions mentioned above. Definition: Nystatin is a mixture of substances produced by the growth of certain strains of Streptomyces noursei, the maincomponent of which is nystatin A1. Nystatin contains not less than 4400 International Units per mg, calculated with reference to the dried substance. | ||
|
1400-61-9 | PRIMARY | |||
|
D009761 | PRIMARY |
Showing 1 to 5 of 20 entries
All of the following components must be present:
ACTIVE MOIETY
(3)